Medigus Ltd (MDGS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Medigus Ltd (MDGS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010915
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medigus Ltd (Medigus) is a medical equipment provider that offers endoscopic procedures and devices. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease by performing fundoplication procedures through the mouth. It offers various rigid, semi-flexible and flexible video endoscopes, SRS endoscope, micro cameras, endoscopy suites, staplers and ultrasound sensors. The company also offers micro cameras for medical endoscopy, remote visual inspection, industrial endoscopy, non-destructive testing and machine vision applications. It markets its products across Israel and abroad. Medigus is headquartered in Omer, Israel.

Medigus Ltd (MDGS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medigus Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigus Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigus Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigus Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Medigus Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigus Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Medigus Enters Into Distribution Agreement With China National Pharma For SRS II Systems 10
Equity Offering 11
Medigus Prices USD1.6 Million in Private Placement of Shares 11
Medigus Prices Public Offering of Units for USD7.5 Million 12
Medigus Raises USD7.1 Million in Public Offering of Shares 13
Medigus Raises USD3 Million in Equity Financing 14
Medigus Raises USD11 Million in Private Placement of Shares and Warrants 15
Medigus Raises USD5.6 Million in Private Placement of Shares and Warrants 17
Medigus Completes Public Offering Of Shares For US$7 Million 18
Medigus Completes Private Placement Of Shares For US$8 Million 19
Medigus Ltd – Key Competitors 20
Medigus Ltd – Key Employees 21
Medigus Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 24, 2017: Medigus Announces Third Quarter 2017 Financial Results 23
Sep 18, 2017: Medigus Announces Second Quarter 2017 Financial Results 24
May 30, 2017: Medigus Announces First Quarter 2017 Financial Results 25
Nov 28, 2016: Medigus Announces Third Quarter 2016 Financial Results 26
Aug 31, 2016: Medigus Announces Second Quarter 2016 Financial Results 27
May 31, 2016: Medigus Announces First Quarter 2016 Financial Results 28
Corporate Communications 29
Sep 29, 2016: Medigus Appoints Industry Veteran Eitan Machover to Board of Directors and Audit Committee; Machover’s appointment fills vacancy and fulfills Nasdaq’s Audit Committee Listing Requirement 29
Legal and Regulatory 30
Jan 16, 2017: Medigus Receives Nasdaq Letter Regarding Bid Price Compliance 30
Product News 31
May 15, 2017: Medigus Announces Japanese and European Patents for micro ScoutCam Microvisual Technology 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Medigus Ltd, Medical Equipment, Key Facts, 2016 2
Medigus Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medigus Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medigus Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medigus Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medigus Ltd, Deals By Market, 2011 to YTD 2017 8
Medigus Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medigus Enters Into Distribution Agreement With China National Pharma For SRS II Systems 10
Medigus Prices USD1.6 Million in Private Placement of Shares 11
Medigus Prices Public Offering of Units for USD7.5 Million 12
Medigus Raises USD7.1 Million in Public Offering of Shares 13
Medigus Raises USD3 Million in Equity Financing 14
Medigus Raises USD11 Million in Private Placement of Shares and Warrants 15
Medigus Raises USD5.6 Million in Private Placement of Shares and Warrants 17
Medigus Completes Public Offering Of Shares For US$7 Million 18
Medigus Completes Private Placement Of Shares For US$8 Million 19
Medigus Ltd, Key Competitors 20
Medigus Ltd, Key Employees 21
Medigus Ltd, Other Locations 22
Medigus Ltd, Subsidiaries 22

★海外企業調査レポート[Medigus Ltd (MDGS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Timken Company
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • IO Biotech ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary IO Biotech ApS (IO Biotech) is a clinical stage biotechnology company, which develops disruptive immune modulating anti-cancer medicines. The company developed a pipeline of first-in-class anti-cancer drugs harnessing a unique technology platform, T-Win. IO Biotech's immuno-oncology therapie …
  • StormGeo AS:石油・ガス:M&Aディール及び事業提携情報
    Summary StormGeo AS (StormGeo) is a weather forecast company that offers professional weather services and decision support for weather sensitive operations. The company operates through segments that include shipping, oil and gas, marine operations, renewable, aviation, cross industry and media. It …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • eircom Holdings (Ireland) Ltd:企業の戦略・SWOT・財務情報
    eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report Summary eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Infant Bacterial Therapeutics AB (IBT B)-製薬・医療分野:企業M&A・提携分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal i …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Co-Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • VIA Technologies Inc (2388):企業の財務・戦略的SWOT分析
    VIA Technologies Inc (2388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Rapid Pathogen Screening Inc-医療機器分野:企業M&A・提携分析
    Summary Rapid Pathogen Screening Inc (Rapid Pathogen) is a biotechnology company that designs, develops, manufactures and markets point-of-care diagnostic tests. The company uses its patented direct sampling micro-filtration and direct multi-planar chromafiltography technology to develop various tes …
  • CareDx Inc (CDNA):企業の製品パイプライン分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Abu Dhabi National Hotels Company:企業の戦略・SWOT・財務分析
    Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi National Hotels Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • Jamaica Public Service Co Ltd:企業の戦略的SWOT分析
    Jamaica Public Service Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Gemdale Corporation:企業の戦略・SWOT・財務分析
    Gemdale Corporation - Strategy, SWOT and Corporate Finance Report Summary Gemdale Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • National Company KazMunayGas-石油・ガス分野:企業M&A・提携分析
    Summary National Company KazMunayGas (KazMunayGas) is a state-owned, vertically integrated oil and gas company. It carries out the acquisition, exploration, development, production, processing, transportation, refining and export of hydrocarbons. The company also produces petrochemicals, stores and …
  • Yoshinoya Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆